Related Experiment Video
Updated: Aug 3, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Association of pericoronary adipose tissue with atrial fibrillation recurrence after ablation based on computed
Guo-Jing Ma1,2, Fu-Qian Guo1, Jie Hu3
1Department of Medical Imaging, The Second Hospital of Hebei Medical University, 215 West Heping Road, Shijiazhuang, 050011, Hebei Province, China.
Insights
Epicardial adipose tissue volume index (EATVI) and left circumflex artery fat attenuation index (LCX-FAI) predict atrial fibrillation (AF) recurrence after ablation. These measurements offer valuable clinical insights for post-ablation AF management.
Area of Science:
- Cardiology
- Medical Imaging
- Biomedical Engineering
Background:
- Pericoronary adipose tissue volume (PCATV) and fat attenuation index (FAI) are primarily studied in coronary artery disease.
- Their association with atrial fibrillation (AF) recurrence post-ablation is less explored.
Purpose of the Study:
- To investigate the correlation between PCATV, FAI, and AF recurrence after radiofrequency ablation.
- To assess the clinical significance of these adipose tissue measurements in predicting AF recurrence.
Main Methods:
- Retrospective analysis of patients with continuous AF undergoing radiofrequency ablation and computed tomographic angiography (CTA).
- Quantitative measurement of PCATV, FAI, epicardial adipose tissue volume (EATV), and EAT density (EATD) around major coronary arteries (LAD, LCX, RCA).
Main Results:
- Among 189 patients, 47 (24.9%) experienced AF recurrence within 12 months.
- Increased 3V-FAI, LCX-FAI, EATV, and EATVI were observed in the recurrence group.
- LCX-FAI and EATVI emerged as significant independent risk factors for AF recurrence, with LCX-FAI demonstrating higher predictive value (AUC 0.722) than EATVI (AUC 0.630).
Conclusions:
- Epicardial adipose tissue volume index (EATVI) and left circumflex artery fat attenuation index (LCX-FAI) are associated with AF recurrence post-ablation.
- These imaging biomarkers hold significant clinical value in predicting AF recurrence, aiding in patient management strategies.
Purpose:
Quantitative measurement of pericoronary adipose tissue volume (PCATV) and fat attenuation index (FAI) has mostly been used in the study of coronary artery related diseases but rarely in the relationship with atrial fibrillation (AF). This study was conducted to investigate the correlation of PCATV and FAI with the AF recurrence after ablation and the clinical significance.
Materials And Methods:
Patients with continuous AF who underwent radiofrequency ablation and computed tomographic angiography (CTA) were retrospectively enrolled. The PCATV, FAI, epicardial adipose tissue volume (EATV) and EAT density (EATD) arround the three main branches of the coronary arteries (LAD, LCX, and RCA) were measured quantitatively with cardiac function software and analyzed.
Results:
189 patients with continuous AF who underwent radiofrequency ablation for the first time were enrolled. After 12-month follow-up with a mean follow-up time of 10.93 ± 0.16 months, 47 (24.9%) patients were confirmed to have AF recurrence. The 3 V-FAI (- 81.17 ± 4.27 vs. - 83.31 ± 4.59 HU, P = 0.005), LCX-FAI (median - 77 vs. median - 81HU, P < 0.001), EATV (median 141.14vs. median 125.39 ml, P = 0.010), and EATVI (median 70.77 vs. 66.73 ml/m2, P = 0.008) were significantly increased in the recurrence group. EATVI (OR 1.043, 95% CI 1.020-1.066) and LCX-FAI (OR 1.254, 95% CI 1.145-1.374) were two significant independent risk factors for AF recurrence. In the comparison of ROC, the predictive value of LCX-FAI (cut-off value of >- 81.5 HU, area under the curve (AUC) of 0.722) was higher than that of EATVI (cut-off value > 81.07 ml/m2, AUC of 0.630).
Conclusion:
EATVI and LCX-FAI were related to recurrence of AF after ablation and have important clinical value in predicting the AF recurrence.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

